Also late yesterday, Boston Scientific (BSX) said the U.S. Food and Drug Administration has approved its latest drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.

FORBES: Health Care News: Merck, Boston Scientific